MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1002/cti2.1249

Медицинская библиотека · Clinical & translational immunology · 2021

Prophylactic antigen-specific T-cells targeting seven viral and fungal pathogens after allogeneic haemopoietic stem cell transplant.

Gottlieb David Jonathan, Clancy Leighton Edward, Withers Barbara, McGuire Helen Marie, Luciani Fabio, Singh Mandeep, Hughes Brendan, Gloss Brian, Kliman David, Ma Chun Kei Kris, Panicker Shyam, Bishop David, Dubosq Ming-Celine, Li Ziduo, Avdic Selmir, Micklethwaite Kenneth, Blyth Emily

СтатьяПеревод в очереди

Аннотация

OBJECTIVES

Adoptive immunotherapy using donor-derived antigen-specific T-cells can prevent and treat infection after allogeneic haemopoietic stem cell transplant (HSCT).

METHODS

We treated 11 patients with a prophylactic infusion of 2 × 107 cells per square metre donor-derived T-cells targeting seven infections (six viral and one fungal) following HSCT. Targeted pathogens were cytomegalovirus (CMV), Epstein-Barr virus (EBV), adenovirus, varicella zoster virus, influenza, BK virus (BKV) and Aspergillus fumigatus.

RESULTS

T-cell products were successfully generated in all patients with 10 products responsive to 6 or 7 infections. T-cell infusions were associated with increases in antigen-experienced activated CD8+ T-cells by day 30. CMV, EBV and BKV reactivation occurred in the majority of patients and was well controlled except where glucocorticoids were administered soon after T-cell infusion. Three patients in that circumstance developed CMV tissue infection. No patient required treatment for invasive fungal infection. The most common CMV and EBV TCR clonotypes in the infusion product became the most common clonotypes seen at day 30 post-T-cell infusion. Donors and their recipients were recruited to the study prior to transplant. Grade III/IV graft-versus-host disease developed in four patients. At a median follow-up of 390 days post-transplant, six patients had died, 5 of relapse, and 1 of multi-organ failure. Infection did not contribute to death in any patient.

CONCLUSION

Rapid reconstitution of immunity to a broad range of viral and fungal infections can be achieved using a multi-pathogen-specific T-cell product. The development of GVHD after T-cell infusion suggests that infection-specific T-cell therapy after allogeneic stem cell transplant should be combined with other strategies to reduce graft-versus-host disease.

Для цитирования: Gottlieb David Jonathan, Clancy Leighton Edward, Withers Barbara, McGuire Helen Marie, Luciani Fabio, Singh Mandeep, Hughes Brendan, Gloss Brian, Kliman David, Ma Chun Kei Kris, Panicker Shyam, Bishop David, Dubosq Ming-Celine, Li Ziduo, Avdic Selmir, Micklethwaite Kenneth, Blyth Emily. Prophylactic antigen-specific T-cells targeting seven viral and fungal pathogens after allogeneic haemopoietic stem cell transplant.. Clinical & translational immunology. 2021. DOI: 10.1002/cti2.1249.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.